Personal information

Other IDs

Scopus Author ID: 55887555700

Activities

Collapse all

Works (17)

Beyond biomarkers: Exploring the diverse potential of a novel phosphoprotein in lung cancer management

Journal of Cellular and Molecular Medicine
2024-09 | Journal article
DOI: 10.1111/jcmm.70077
Contributors: Amirabbas Rostami; Ehsan Ranjbar; Somayeh Amiri; Fatemeh Ezzatifar
Source: check_circle
Crossref

Recent highlights in the immunomodulatory aspects of Treg cell-derived extracellular vesicles: special emphasis on autoimmune diseases and transplantation

Cell and Bioscience
2022 | Journal article
DOI: 10.1186/s13578-022-00808-4
EID:

2-s2.0-85130721089

Part of ISSN: 20453701
Contributors: Asemani, Y.; Najafi, S.; Ezzatifar, F.; Zolbanin, N.M.; Jafari, R.
Source: Self-asserted source
fatemeh Ezzatifar via Scopus - Elsevier

TGF-β1 receptor blockade attenuates unilateral ureteral obstruction-induced renal fibrosis in C57BL/6 mice through attenuating Smad and MAPK pathways

Journal of Molecular Histology
2022 | Journal article
DOI: 10.1007/s10735-022-10078-6
EID:

2-s2.0-85132260254

Part of ISSN: 15672387 15672379
Contributors: Nazari Soltan Ahmad, S.; Kalantary-Charvadeh, A.; Hamzavi, M.; Ezzatifar, F.; Aboutalebi Vand Beilankouhi, E.; Toofani-Milani, A.; Geravand, F.; Golshadi, Z.; Mesgari-Abbasi, M.
Source: Self-asserted source
fatemeh Ezzatifar via Scopus - Elsevier

The Role of the IL-33/ST2 Immune Pathway in Autoimmunity: New Insights and Perspectives

Immunological Investigations
2022 | Journal article
DOI: 10.1080/08820139.2021.1878212
EID:

2-s2.0-85100300584

Part of ISSN: 15324311 08820139
Contributors: Ramezani, F.; Babaie, F.; Aslani, S.; Hemmatzadeh, M.; Mohammadi, F.S.; Gowhari-Shabgah, A.; Jadidi-Niaragh, F.; Ezzatifar, F.; Mohammadi, H.
Source: Self-asserted source
fatemeh Ezzatifar via Scopus - Elsevier

Association of the genetic variants in the endoplasmic reticulum aminopeptidase 2 gene with ankylosing spondylitis susceptibility

International Journal of Rheumatic Diseases
2021 | Journal article
DOI: 10.1111/1756-185X.14079
EID:

2-s2.0-85100530372

Part of ISSN: 1756185X 17561841
Contributors: Ebrazeh, M.; Ezzatifar, F.; Torkamandi, S.; Mohammadi, F.S.; Salimifard, S.; Gowhari Shabgah, A.; Hemmatzadeh, M.; Aslani, S.; Babaie, F.; Jadidi-Niaragh, F. et al.
Source: Self-asserted source
fatemeh Ezzatifar via Scopus - Elsevier

Chemokine CXCL14; a double-edged sword in cancer development

International Immunopharmacology
2021 | Journal article
DOI: 10.1016/j.intimp.2021.107681
EID:

2-s2.0-85105834111

Part of ISSN: 18781705 15675769
Contributors: Gowhari Shabgah, A.; Haleem Al-qaim, Z.; Markov, A.; Valerievich Yumashev, A.; Ezzatifar, F.; Ahmadi, M.; Mohammad Gheibihayat, S.; Gholizadeh Navashenaq, J.
Source: Self-asserted source
fatemeh Ezzatifar via Scopus - Elsevier

CiRS-7/CDR1as; An oncogenic circular RNA as a potential cancer biomarker

Pathology Research and Practice
2021 | Journal article
DOI: 10.1016/j.prp.2021.153639
EID:

2-s2.0-85116885306

Part of ISSN: 16180631 03440338
Contributors: Rahmati, Y.; Asemani, Y.; Aghamiri, S.; Ezzatifar, F.; Najafi, S.
Source: Self-asserted source
fatemeh Ezzatifar via Scopus - Elsevier

Curcumin and cancer; are long non-coding RNAs missing link?

Progress in Biophysics and Molecular Biology
2021 | Journal article
DOI: 10.1016/j.pbiomolbio.2021.04.001
EID:

2-s2.0-85106641518

Part of ISSN: 00796107
Contributors: Gowhari Shabgah, A.; Hejri Zarifi, S.; Mazloumi Kiapey, S.S.; Ezzatifar, F.; Pahlavani, N.; Soleimani, D.; Mohammadian Haftcheshmeh, S.; Mohammadi, H.; Gholizadeh Navashenaq, J.
Source: Self-asserted source
fatemeh Ezzatifar via Scopus - Elsevier

CXC chemokine ligand 16: A Swiss army knife chemokine in cancer

Expert Reviews in Molecular Medicine
2021 | Journal article
DOI: 10.1017/erm.2021.7
EID:

2-s2.0-85104703968

Part of ISSN: 14623994
Contributors: Shabgah, A.G.; Qasim, M.T.; Mostafavi, S.M.; Zekiy, A.O.; Ezzatifar, F.; Ahmadi, M.; Haftcheshmeh, S.M.; Navashenaq, J.G.
Source: Self-asserted source
fatemeh Ezzatifar via Scopus - Elsevier

Matrix metalloproteinases are involved in the development of neurological complications in patients with Coronavirus disease 2019

International Immunopharmacology
2021 | Journal article
DOI: 10.1016/j.intimp.2021.108076
EID:

2-s2.0-85113298946

Part of ISSN: 18781705 15675769
Contributors: Mohammadhosayni, M.; Sadat Mohammadi, F.; Ezzatifar, F.; Mahdavi Gorabi, A.; Khosrojerdi, A.; Aslani, S.; Hemmatzadeh, M.; Yazdani, S.; Arabi, M.; Marofi, F. et al.
Source: Self-asserted source
fatemeh Ezzatifar via Scopus - Elsevier

microRNAs: Small molecules with a large impact on colorectal cancer

Biotechnology and Applied Biochemistry
2021 | Journal article
DOI: 10.1002/bab.2255
EID:

2-s2.0-85116920784

Part of ISSN: 14708744 08854513
Contributors: Moazzendizaji, S.; Sevbitov, A.; Ezzatifar, F.; Jalili, H.R.; Aalii, M.; Hemmatzadeh, M.; Aslani, S.; Gholizadeh Navashenaq, J.; Safari, R.; Hosseinzadeh, R. et al.
Source: Self-asserted source
fatemeh Ezzatifar via Scopus - Elsevier

Arctigenin, an anti-tumor agent; a cutting-edge topic and up-to-the-minute approach in cancer treatment

European Journal of Pharmacology
2021-10 | Journal article
DOI: 10.1016/j.ejphar.2021.174419
Contributors: Arezoo Gowhari Shabgah; Wanich Suksatan; Muhammad Harun Achmad; Dmitry O. Bokov; Walid Kamal Abdelbasset; Fatemeh Ezzatifar; Sasan Hemmati; Hamed Mohammadi; Davood Soleimani; Farhad Jadidi-Niaragh et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Shedding more light on the role of Midkine in hepatocellular carcinoma: New perspectives on diagnosis and therapy

IUBMB Life
2021-04 | Journal article
DOI: 10.1002/iub.2458
Contributors: Arezoo Gowhari Shabgah; Fatemeh Ezzatifar; Surendar Aravindhan; Angelina Olegovna Zekiy; Majid Ahmadi; Seyed Mohammad Gheibihayat; Jamshid Gholizadeh Navashenaq
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Susceptibility to ERAP1 gene single nucleotide polymorphism modulates the inflammatory cytokine setting in ankylosing spondylitis

International Journal of Rheumatic Diseases
2019 | Journal article
DOI: 10.1111/1756-185X.13494
EID:

2-s2.0-85061454452

Part of ISSN: 1756185X 17561841
Contributors: Hemmatzadeh, M.; Babaie, F.; Ezzatifar, F.; Mohammadi, F.S.; Ebrazeh, M.; Golabi Aghdam, S.; Hajaliloo, M.; Azizi, G.; Gowhari Shabgah, A.; Shekari, N. et al.
Source: Self-asserted source
fatemeh Ezzatifar via Scopus - Elsevier

Development and characterization of monoclonal antibodies against human IgA in Balb/c mice

Human Antibodies
2015 | Journal article
DOI: 10.3233/HAB-140277
EID:

2-s2.0-84925734928

Part of ISSN: 1875869X 10932607
Contributors: Ezzatifar, F.; Majidi, J.; Baradaran, B.; Maleki, L.A.; Abdolalizadeh, J.; Yousefi, M.
Source: Self-asserted source
fatemeh Ezzatifar via Scopus - Elsevier

Large scale generation and characterization of anti-human IgA monoclonal antibody in ascitic fluid of balb/c mice

Advanced Pharmaceutical Bulletin
2015 | Journal article
DOI: 10.5681/apb.2015.013
EID:

2-s2.0-84924553814

Part of ISSN: 22517308 22285881
Contributors: Ezzatifar, F.; Majidi, J.; Baradaran, B.; Maleki, L.A.; Abdolalizadeh, J.; Yousefi, M.
Source: Self-asserted source
fatemeh Ezzatifar via Scopus - Elsevier

A unique report: Development of super anti-human IgG monoclone with optical density over than 3

Advanced Pharmaceutical Bulletin
2013 | Journal article
DOI: 10.5681/apb.2013.054
EID:

2-s2.0-84885693433

Part of ISSN: 22517308 22285881
Contributors: Maleki, L.A.; Baradaran, B.; Abdolalizadeh, J.; Ezzatifar, F.; Majidi, J.
Source: Self-asserted source
fatemeh Ezzatifar via Scopus - Elsevier

Peer review (35 reviews for 8 publications/grants)

Review activity for Biomedicine & pharmacotherapy. (6)
Review activity for Cell & bioscience. (5)
Review activity for Cellular signalling. (10)
Review activity for Clinica chimica acta. (6)
Review activity for Computer methods and programs in biomedicine. (1)
Review activity for Medical oncology. (5)
Review activity for Pathology, research and practice. (1)
Review activity for The international journal of biochemistry & cell biology. (1)
How many people are using ORCID?